We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,048,396
B-North is a UK-based business lending company. It has combined cloud-native technology with face-to-face relationship banking. The company asserts that SMEs account for over 60% of private-sector employment in the UK, have driven job growth over the past ten years, and are central to driving economic recovery. It intends to disrupt the £150 billion UK Small and Medium Enterprise (SME) lending market. B-North has raised a seed capital of over £6.8 million including a six-figure investment from the Greater Manchester Combined Authority to establish its core team, as well as, build lending and deposit-taking platforms. The company is now seeking further investment through a bridge round to extend the cash runway from the end of Q4 2020 into Q1-Q2 2021 to achieve the necessary regulatory capital to become a bank and commence lending.
days to go: Expired investment: £2,149,256
Quotall is a specialist insurance technology software entity that helps large, high profile enterprises to enter the insurance market. The company claims that to date, brands have struggled to extend into insurance due to significant up-front costs, regulatory concerns, legacy technology in the insurance sector and a lack of in-house expertise. Quotall claims that its insurance ecosystem service aims to remove these barriers and enable rapid market entry. The company asserts that it can arrange regulatory approval for the client and link the latter's customers through to its fully client-branded, quote, buy and self-service insurance platform. Quotall's earned revenues in 2020 reached close to £500,000 and it has raised £4 million to date. It states it will use the investment to resource the implementation, development, and servicing of new client accounts as they are contracted.
days to go: Expired investment: £708,805
Super U is a health food brand, creating great-tasting and nutritious superfood blends and providing a natural, innovative & convenient way of consuming superfoods, without costing the Earth. The company has 3500+ online consumers and, the social audience has risen to over 8,500 followers. Additionally, Super U has been a finalist for Start-Up Business of the Year and Health & Beauty Business of the Year 2019 - for the Great British Entrepreneur Awards. The funds will be used for growth, marketing and export strategies.
days to go: Expired investment: £160,110
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £270,543
Tribal Sports Nutrition is a real food active nutrition company.  They are focused on bring the baobab fruit from Africa to everyday lives in the form of a fruit smoothie.  The investment will enable Tribal to unlock their global potential.
days to go: Expired investment: £149,310
We Are Colony are a global film streaming platform that are connecting filmmakers to fans through exclusive content.  
days to go: Expired investment: £443,106
Hexis is a fitness application that helps users become fitter scientifically, fuel smarter and feel on top of their game. The company argues that despite users becoming knowledgeable in fitness, courtesy of the internet, nutrition hasn’t become a core area of concern. Hexis asserts that its proprietary 'Carb Coding' tool amplifies the human body's response to exercise, enhancing performance, recovery and adaptation. Hexis stresses that its tool removes the guesswork from nutrition by predictively personalising a user's requirements as per their workouts and lifestyle. The company points out that its beta system was tested on 1,000 users. It aspires to dominate the personalised nutrition market that is set to grow to £11.7 billion by 2027 and counts athletes like Paul Dunne (Golf), Rohan Dennis (Cycling), and Lauren Delany (Rugby) amongst its star users. Hexis states it will use the investment to democratise nutrition and increase its user base across global markets.

Pitch Rated

87%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £398,234
Balkerne is designing a commercial insurance product based on Risk Management technology and Property & Casualty Insurance. Through this way, the company helps enterprises defend their property and people. The company will make sure that no property owner suffers from theft, fire or flood. It has generated net revenue of £21K in January 2019. The revenue model of Balkerne is to charge a percentage of the premium to distribute insurance and support customers with risk management by managing claims. The company has come up with an exit strategy that is to improve the performance of the acquiring company and to quickly acquire the skills and technologies at a lower cost.
days to go: Expired investment: £150,000
Arca have introduced new tools for property risk management and created a marketplace to trade portfolio risks to match buyers and sellers of financial products connected to the performance of real estate. They are opening up the concept of short term property market risk management for property portfolio managers.  
days to go: Expired investment: £575,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph